Fig 4. Patient survival (left) and ESKD-free survival rate (right) of patients with Schimke immunoosseous dysplasia diagnosed based on phenotype vs. patients diagnosed incidentally through SRNS-panel gene testing.

Patients who deceased before reaching ESKD were censored in the renal survival analysis.